share_log

Gemphire Therapeutics | SC14D9C: Written communication by the subject company relating to a third party tender offer

SEC ·  May 22, 2006 19:29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more